<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210523051370N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-10-12</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of pomegranate peel extract on the prevention of ventilator-associated pneumonia</public_title>
      <acronym></acronym>
      <scientific_title>The comparative effects of mouthwash containing pomegranate peel extract (Punica granatum) and chlorhexidin 0.2% on the prevention of ventilator associated pneumonia in patients admitted to intensive care units</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57627</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: We will only take chest X-rays (CXR) for patients suspected of having pneumonia. An assessor with intensive care subspecialty will interpret the CXRs. Oral care and using mouthwash (0.2% chlorhexidine for the control group and pomegranate peel extract mouthwash for the experimental group) will be performed twice a day (every 12 hours) for five consecutive days. The assessor will check and record the Clinical Pulmonary Infection Score (CPIS) of all patients on the first, third, and fifth days. A dentist has adequately trained the nurse who applies the mouthwash and checks the patients' oral condition, Randomization description: A total of 120 eligible patients will be selected based on convenience sampling. The researchers will allocate them to experimental (A) and control groups (B) using block randomization. When the block size is four, there are six possible sequences of letter placement (i.e., AABB1-ABBA2-BABA3-BBAA4-BABA5-ABAB6). Then, using Random Allocation Software 2.0, one of the numbers from one to six is randomly selected thirty times. Each number determines four modes of placement in a block. The blocks of four participants are randomly placed in 30 opaque envelopes and arranged based on their numbers. A person who is not a member of the research team and is unaware of the research objectives and the participant’s allocation in the study groups will seal the envelopes. The researcher will open the envelopes in order and assign the patients to the relevant groups. The assessor will also be blind to the random assignment of patients in the groups, Blinding description: The assessor will be blind to the random assignment of patients in the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Ventilator-associated pneumonia.</hc_freetext>
      <i_freetext>Intervention 1: Before using mouthwash, the pneumonia is assessed using the Clinical Pulmonary Infection Score (CPIS). To apply the mouthwash in the experimental and control groups, the researcher will prepare the required equipment at the patient's bedside. It includes suction, suction tip, Nelaton Catheter FG 14, toothpaste, toothbrush, moisturizing cream, 0.9% normal saline, 5 CC syringe, gloves, pomegranate peel extract mouthwash, scissors, bandage, and regular gauze. Then, the ICU nurse (someone other than the researchers) washes her hands, wears gloves, puts one centimeter of fluoride Signal toothpaste  on a soft toothbrush, and brushes all the surfaces of the teeth (i.e., buccal, lingual/palatal, and the gum surfaces) with rotating along with up-down movements for 2 minutes. Then, she cleanses the surface of the teeth and mouth with 5 CC of 0.9% normal saline and simultaneously suctions it for 30 seconds. In the experimental group, the nurse, who is trained how to brush teeth and how to use chlorhexidine and pomegranate peel extract mouthwashes, will apply 20 CC of 5% pomegranate peel extract mouthwash twice a day using a syringe. Then, she cleanses the teeth, tongue, gum, and oral mucosa and simultaneously suctions the mouth and pharynx for 30 seconds. Intervention 2: To apply the mouthwash in the control groups, the researchers will prepare the required equipment at the patient's bedside. It includes suction, suction tip, Nelaton Catheter FG 14, toothpaste, toothbrush, moisturizing cream, 0.9% normal saline, 5 CC syringe, gloves, 0.2% chlorhexidine solution, scissors, bandage, and regular gauze. Then, the ICU nurse (someone other than the researchers) washes her hands, wears gloves, puts one centimeter of fluoride Signal toothpaste on a soft toothbrush, and brushes all the surfaces of the teeth (i.e., buccal, lingual/palatal, and the gum surfaces) with rotating along with up-down movements for 2 minutes. Then, she cleanses the surface of the teeth and mouth with 5 CC of 0.9% normal saline and simultaneously suctions it for 30 seconds. In the control group, the nurse will apply 10 CC of 0.2% chlorhexidine mouthwash solution twice a day on the teeth, tongue, gums, and oral mucosa and simultaneously suctions the mouth and pharynx for 30 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is All data will be kept confidential</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Seyed Afshin Shorofi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Square. Three_way Joibar. Mazandaran University of Medical Sciences</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4815733971</zip>
        <telephone>+98 11 3336 7342</telephone>
        <email>ashorofi@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Afshin Shorofi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Square. Three_way Joibar. Mazandaran University of Medical Sciences</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4815733971</zip>
        <telephone>+98 11 3336 7342</telephone>
        <email>ashorofi@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients aged 18-65 years
Having a tracheal tube
Up to 12  hours to elapse after ICU admission
Not affected by immune system disorders or lung diseases, including pneumonia, asthma, and allergic rhinitis
Having natural teeth
Not simultaneously participating in other interventional studies</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with tracheostomy tube
A history of taking antibiotics during the last two weeks
A history of allergy to chlorhexidine and herbal mouthwashes
Reintubation
Severe maxillofacial trauma
Pregnant and lactating patients
A history of malignancy and cancer
A history of head and neck radiotherapy
A history of oral mucositis and periodontal diseases
Patients with sepsis and COVID-19 in admission
Patients with COVID-19 in admission</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J95.851</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>ventilator-associated pneumonia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Before using mouthwash, the pneumonia is assessed using the Clinical Pulmonary Infection Score (CPIS). To apply the mouthwash in the experimental and control groups, the researcher will prepare the required equipment at the patient's bedside. It includes suction, suction tip, Nelaton Catheter FG 14, toothpaste, toothbrush, moisturizing cream, 0.9% normal saline, 5 CC syringe, gloves, pomegranate peel extract mouthwash, scissors, bandage, and regular gauze. Then, the ICU nurse (someone other than the researchers) washes her hands, wears gloves, puts one centimeter of fluoride Signal toothpaste  on a soft toothbrush, and brushes all the surfaces of the teeth (i.e., buccal, lingual/palatal, and the gum surfaces) with rotating along with up-down movements for 2 minutes. Then, she cleanses the surface of the teeth and mouth with 5 CC of 0.9% normal saline and simultaneously suctions it for 30 seconds. In the experimental group, the nurse, who is trained how to brush teeth and how to use chlorhexidine and pomegranate peel extract mouthwashes, will apply 20 CC of 5% pomegranate peel extract mouthwash twice a day using a syringe. Then, she cleanses the teeth, tongue, gum, and oral mucosa and simultaneously suctions the mouth and pharynx for 30 seconds.</i_keyword>
      <i_keyword>To apply the mouthwash in the control groups, the researchers will prepare the required equipment at the patient's bedside. It includes suction, suction tip, Nelaton Catheter FG 14, toothpaste, toothbrush, moisturizing cream, 0.9% normal saline, 5 CC syringe, gloves, 0.2% chlorhexidine solution, scissors, bandage, and regular gauze. Then, the ICU nurse (someone other than the researchers) washes her hands, wears gloves, puts one centimeter of fluoride Signal toothpaste on a soft toothbrush, and brushes all the surfaces of the teeth (i.e., buccal, lingual/palatal, and the gum surfaces) with rotating along with up-down movements for 2 minutes. Then, she cleanses the surface of the teeth and mouth with 5 CC of 0.9% normal saline and simultaneously suctions it for 30 seconds. In the control group, the nurse will apply 10 CC of 0.2% chlorhexidine mouthwash solution twice a day on the teeth, tongue, gums, and oral mucosa and simultaneously suctions the mouth and pharynx for 30 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Clinical Pulmonary Infection Score. According to the CPIS, a score of 6 or higher indicates mechanical ventilator-associated pneumonia. Timepoint: The assessor will check and record the  Clinical Pulmonary Infection Score of all patients on first, third and fifth days. Method of measurement: Pulmonary of Infection Survey Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-06-08</approval_date>
        <contact_name>Bioethics Committee of Mazandaran University  of Medical Sciences</contact_name>
        <contact_address>Moalem Square, Sari, Mazandaran Province sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
